Xiaoli Cao

2.8k citations
134 papers · 2.0k indexed · h-index 26
Topics
Antibiotic Resistance in Bacteria (34 papers)MicroRNA in disease regulation (10 papers)Cancer-related molecular mechanisms research (10 papers)
Partner nations
ChinaUnited StatesJapan

In The Last Decade

Xiaoli Cao

124 papers receiving 2.0k citations

Peers

Xiaoli Cao
Comparison fields: 5 of 133
  • Molecular Biology 657
  • Molecular Medicine 507
  • Epidemiology 301
  • Cancer Research 275
  • Endocrinology 272
Replace Jung Min Kim with:
Jung Min Kim South Korea
Yongmei Hu China
Yuan Lu China
Jinbo Liu China
Xi Li China
Hua Gao China
Yehudit Bergman United States
Santiago Redondo Spain
Ming Jiang China
Tong Wang China
Xiaoli Cao relative to Jung Min Kim South Korea Jung Min Kim's profile →
Citations per field
00.5×
Jung Min Kim · 1×
Citations per year

Countries citing papers authored by Xiaoli Cao

Since Specialization
Citations

This map shows the geographic impact of Xiaoli Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoli Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoli Cao more than expected).

Fields of papers citing papers by Xiaoli Cao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoli Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoli Cao. The network helps show where Xiaoli Cao may publish in the future.

Co-authorship network of co-authors of Xiaoli Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoli Cao. A scholar is included among the top collaborators of Xiaoli Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoli Cao. Xiaoli Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 0
4 1
5 1
6 0
7 0
8 4
9 2
10 4
11 11
12 16
13 20
14 12
15 36
16 16
17
Association of variants in CELSR2-PSRC1-SORT1 with risk of serum lipid traits, coronary artery disease and ischemic stroke.
26
18 17
19 2
20 18

About Xiaoli Cao

Xiaoli Cao is a scholar working on Molecular Medicine, Endocrinology and Applied Microbiology and Biotechnology, having authored 134 papers that have together received 2.0k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (34 papers), MicroRNA in disease regulation (10 papers) and Cancer-related molecular mechanisms research (10 papers). The work is most often cited by research in Molecular Medicine (507 citations), Endocrinology (272 citations) and Applied Microbiology and Biotechnology (84 citations). Xiaoli Cao has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Rui‐Xing Yin, Wu‐Xian Chen, Han Shen, Dong‐Feng Wu, Jin‐Zhen Wu, Zhifeng Zhang, Wanqing Zhou, Lynn Htet Htet Aung, Kui Zhang and Junhao Chen. Their work appears in journals such as Blood, Journal of the American College of Cardiology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026